Holly Symonds Clark, Ph.D., is the Associate Director of the Commercialization Team for UK Innovate's Technology Commercialization. She manages UK's therapeutics portfolio and works with UK Innovators to develop commercialization strategies to maximize the long-term impact of each technology.  In addition, Holly builds relationships with and directs UK Innovate's resources to industry partners and university collaborators while identifying opportunities for UK innovations.

Previously, Holly was the Deputy Director of the University of Louisville's technology transfer office. She helped direct the office and managed new health-related UofL innovations, which involved intellectual property protection, technology marketing, license negotiation, and commercialization. She was also a Senior Technology Transfer Specialist at the National Cancer Institute. Holly has a B.S. in biology/genetics from the University of Maryland and a Ph.D. in molecular biology from the University of Pittsburgh.